scholarly journals Unresectable hepatocellular carcinoma(HCC) with long term survival by percutaneous transhepatic portal embolization(PTPE) following transcatheter arterial embolization(TAE).

Kanzo ◽  
1993 ◽  
Vol 34 (10) ◽  
pp. 844-848 ◽  
Author(s):  
Masashi TAKEMURA ◽  
Hiroaki KINOSHITA ◽  
Kazuhiro HIROHASHI ◽  
Shoji KUBO ◽  
Ryutaro IWASA ◽  
...  
2004 ◽  
Vol 11 (S2) ◽  
pp. S73-S73
Author(s):  
C. P. Raut ◽  
F. Izzo ◽  
P. Marra ◽  
L. M. Ellis ◽  
J. N. Vauthey ◽  
...  

2005 ◽  
Vol 12 (8) ◽  
pp. 616-628 ◽  
Author(s):  
Chandrajit P. Raut ◽  
Francesco Izzo ◽  
Paolo Marra ◽  
Lee M. Ellis ◽  
Jean-Nicolas Vauthey ◽  
...  

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. e14559-e14559
Author(s):  
R. Dhanasekaran ◽  
E. B. McIntosh ◽  
J. S. Kauh ◽  
D. A. Kooby ◽  
B. F. El-Rayes ◽  
...  

Medicine ◽  
2018 ◽  
Vol 97 (33) ◽  
pp. e11872 ◽  
Author(s):  
Jie-Yu Kong ◽  
Shu-Mei Li ◽  
Hai-Yan Fan ◽  
Lan Zhang ◽  
Hui-Jin Zhao ◽  
...  

1986 ◽  
Vol 72 (4) ◽  
pp. 409-411 ◽  
Author(s):  
Giuseppe Giaccone ◽  
Gianmaria Bonardi ◽  
Gabriella Leria ◽  
Michela Donadio ◽  
Alessandro Calciati

Hepatocellular carcinoma has a poor prognosis and is poorly responsive to systemic chemotherapy. Here we describe a case with unresectable hepatocellular carcinoma who achieved a complete response and has survived for more than 2 years, following treatment with a combination of adriamycin and etoposide (VP 16-213).


Sign in / Sign up

Export Citation Format

Share Document